New Delhi, Jan 6 (PTI) Drug firm Cipla on Monday said it has launched a mobile application designed to enable the first line of screening for asthma in India.

According to the Global Burden of Disease report, the total burden of asthma in India is estimated to be around 34.3 million.

Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for January 6, 2024 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game.

India has a three-fold higher mortality rate and two-fold higher asthma-associated disability burden compared to the global proportion.

This can be attributed, in part, to the underdiagnosis and undertreatment of asthma.

Also Read | Shillong Teer Results Today, January 6 2025: Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

"By leveraging the power of next-gen technologies, we are developing solutions that are fundamentally transforming patient care and enabling better diagnostic, treatment, and management outcomes," Cipla Managing Director & Global CEO Umang Vohra said in a statement.

The mobile application -- CipAir will be available on Android and will be subsequently rolled out on iOS devices, the company stated.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)